StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
FDA Approves Sarepta Therapeutics' (SRPT) Eteplirsen
September 19, 2016 9:52 AM
(Updated - September 19, 2016 9:56 AM EDT)The U.S. Food and Drug Administration today approved Sarepta Therapeutics' (Nasdaq: SRPT) Exondys ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Momentum Movers
Trader Talk
Trading Halts
Next Articles
Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
September 20, 2016 1:18 PM
Sarepta Therapeutic (SRPT) PT Raised to $66 at Wedbush
September 20, 2016 7:21 AM
UPDATE: Cowen Upgrades Sarepta Therapeutic (SRPT) to Outperform
September 20, 2016 6:41 AM
Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/Year
September 19, 2016 4:13 PM
Jefferies Upgrades Sarepta Therapeutic (SRPT) to Hold
September 19, 2016 3:29 PM
JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform
September 19, 2016 3:04 PM
Sarepta Therapeutic (SRPT) PT Raised to $81 at Needham & Company
September 19, 2016 1:37 PM
Sarepta Therapeutics (SRPT) to Hold 4PM ET Investor Call - Bloomberg, Citing PR Agency
September 19, 2016 1:37 PM
Leerink Partners Upgrades Sarepta Therapeutic (SRPT) to Market Perform
September 19, 2016 1:29 PM
Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval
September 19, 2016 1:08 PM
SunTrust Upgrades Sarepta Therapeutic (SRPT) to Neutral
September 19, 2016 11:43 AM
Sarepta Therapeutics (SRPT) Shorts Squeezed After Eteplirsen Receives FDA Approval
September 19, 2016 11:27 AM
Sarepta Therapeutics (SRPT) Pushes to Highs Following FDA Approval; +90%
September 19, 2016 11:21 AM
Piper Jaffray Upgrades Sarepta Therapeutic (SRPT) to Overweight
September 19, 2016 10:58 AM
Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
September 19, 2016 10:41 AM
Sarepta Therapeutic (SRPT) Label More Inclusive Than Anticipated - Oppenheimer
September 19, 2016 10:40 AM
William Blair Upgrades Sarepta Therapeutic (SRPT) to Outperform
September 19, 2016 10:35 AM
Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen Approval
September 19, 2016 9:59 AM
